Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9® lead to promotion versus suppression of prostate cancer metastasis

Tzu Hua Lin, Soo Ok Lee, Yuanjie Niu, Defeng Xu, Liang Liang, Lei Li, Shauh Der Yeh, Naohiro Fujimoto, Shuyuan Yeh, Chawnshang Chang

研究成果: 雜誌貢獻 › 文章 › 同行評審

106 引文 斯高帕斯（Scopus）

指紋

深入研究「Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9® lead to promotion versus suppression of prostate cancer metastasis」主題。共同形成了獨特的指紋。

Pharmacology, Toxicology and Pharmaceutical Science